Alabama Dermatology Society 2013 Dermatology Summer Symposium
Erythroderma dermatology 2017
-
Upload
azadi-educational-hospitalduhok -
Category
Health & Medicine
-
view
131 -
download
0
Transcript of Erythroderma dermatology 2017
![Page 1: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/1.jpg)
1
Erythroderma
Basic Dermatology Curriculum
Updated August 5, 2011
![Page 2: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/2.jpg)
Module Instructions
The following module contains a number of blue, underlined terms which are hyperlinked to the dermatology glossary, an illustrated interactive guide to clinical dermatology and dermatopathology.
We encourage the learner to read all the hyperlinked information.
2
![Page 3: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/3.jpg)
Goals and Objectives The purpose of this module is to help medical students
develop a clinical approach to the evaluation and initial management of patients presenting with erythroderma.
By completing this module, the learner will be able to: • Identify and describe the morphology of erythroderma • Name common diseases and medications associated with
erythroderma • Explain the potential morbidity and mortality in erythrodermic
patients • Discuss the initial management of an erythrodermic patient
3
![Page 4: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/4.jpg)
Erythroderma: The Basics Also called exfoliative dermatitis Defined as generalized redness or scaling of the
skin, affecting a significant portion (over 90%) of the body surface area (BSA)
• Vesicles and pustules are usually absent • May present with extensive telogen effluvium
Erythroderma is not a specific diagnosis, but the clinical manifestation of a variety of underlying diseases
4
![Page 5: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/5.jpg)
Erythroderma: Clinical Presentation
Usually evolves slowly over months to years* • Common symptoms include: fevers, chills, malaise and pruritus • Patients may also experience peripheral edema,
lymphadenopathy, secondary skin infection • Long-standing severe erythroderma is associated with diffuse
alopecia (hair loss), keratoderma (hyperkeratosis of the stratum corneum), nail dystrophy (nail plate abnormalities), and ectropion (outward turning of the lower eyelid)
Significant risk for morbidity and mortality, accounting for 1% of all dermatologic admissions to the hospital
Complications of erythroderma include sepsis and high-output cardiac failure
5
* Except for drug reactions, which tend to develop more acutely
![Page 6: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/6.jpg)
6
Medications Implicated in Erythroderma
The most commonly implicated drugs include: • Anti-epileptics • Allopurinol • Antibiotics
• Penicillin • Sulfonamides • Vancomycin
• Calcium channel blockers • Cimetidine • Dapsone • Gold • Lithium • Quinidine
![Page 7: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/7.jpg)
Case One Mr. Robert Ashton
7
![Page 8: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/8.jpg)
Case One: History HPI: Mr. Ashton is a 63-year-old man who presents to
the dermatology clinic with a rapid progression of skin redness, which is covering most of his body
PMH: coronary artery disease s/p 3v CABG, hypertension, psoriasis
Medications: beta-blocker, aspirin, ace-inhibitor, statin, and topical clobetasol. No new medications.
Allergies: none Family history: no history of skin disorders Social history: lives by himself in an apartment Health-related behaviors: no tobacco, alcohol or drug
use ROS: pruritus, fatigue
8
![Page 9: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/9.jpg)
Case One: Exam
Vital signs: T 38.0 (100.4ºF), BP 95/68, HR 115, RR16, O2 Sat 97%
Gen: no acute distress, patient is shivering
Skin: diffuse erythema with overlying scale covering > 90% of the BSA
Mucosal: no mucous membrane involvement
9
![Page 10: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/10.jpg)
Evaluation of Erythroderma In general, evaluation of erythroderma begins with a
thorough history, including a complete medication history
Physical exam requires special attention to the vital signs, nails, mucosa, lymph nodes and evaluation for hepatosplenomegaly
Baseline blood work, skin biopsy and, at times, cytologic or histologic evaluation of lymph nodes is the next step in evaluation • Multiple (and repeat) skin biopsies may be necessary
to make a definitive diagnosis
10
![Page 11: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/11.jpg)
Evaluation of Erythroderma
Underlying malignancy may need to be excluded
Regardless of the underlying cause, if a patient appears unstable or toxic, admission to the hospital is recommended
The evaluation of a patient with erythroderma should include a dermatology consult
11
![Page 12: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/12.jpg)
Back to Case One Mr. Ashton is a 63-year-old man with a history of psoriasis
who presented with generalized erythema. Given his concerning vital signs, Mr. Ashton was admitted to the
hospital for evaluation and treatment.
12
![Page 13: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/13.jpg)
Case One, Question 1
What is the most likely diagnosis in this case?
a. Atopic dermatitis flare b. Cutaneous T-cell lymphoma c. Idiopathic d. Psoriatic erythroderma e. S. aureus scalded skin syndrome
13
![Page 14: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/14.jpg)
Case One, Question 1 Answer: d What is the most likely diagnosis in this case?
a. Atopic dermatitis flare (no history of atopic dermatitis. AD erythroderma tends to present more with weeping and crusting)
b. Cutaneous T-cell lymphoma (hard to tell the difference, but CTCL erythroderma may present with symmetric islands of uninvolved skin. Also may spare areas of skin that are frequently folded, such as the abdomen)
c. Idiopathic d. Psoriatic erythroderma (patient has known psoriasis) e. S. aureus scalded skin syndrome (usually presents with
cutaneous tenderness and widespread superficial blistering and denudation)
![Page 15: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/15.jpg)
Erythroderma: Etiology
Frequently the result of the generalization of an underlying dermatosis
• Psoriasis • Atopic dermatitis • Chronic actinic dermatitis
Drug eruptions Idiopathic Malignancy
• Cutaneous T-cell lymphoma • Paraneoplastic erythroderma
• Seborrheic dermatitis • Pityriasis rubra pilaris • Allergic contact dermatitis
15
![Page 16: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/16.jpg)
Psoriatic Erythroderma Erythrodermic psoriasis is a severe form of
psoriasis that can arise acutely or follow a more chronic course
Can arise in patients with long-standing psoriasis or can occur de novo as the initial presentation of psoriasis
There are a number of triggers for erythrodermic psoriasis, including: • Discontinuation of potent topical or oral treatment,
medications used for other conditions, infection (including HIV), pregnancy and emotional stress
16
![Page 17: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/17.jpg)
Case Two Mrs. Grace Barringer
17
![Page 18: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/18.jpg)
Case Two: History HPI: Mrs. Barringer is a 54-year-old woman with progressive
redness, starting on the scalp and progressing towards the trunk and extremities over the last three weeks
PMH: asthma, chronic dry, itchy skin, and hay fever Medications: daily multivitamin, albuterol inhaler as needed,
moisturizers, occasional antihistamines Allergies: none Family history: noncontributory Social history: lives with her husband, has three grown
children Health-related behaviors: no tobacco, alcohol or drug use ROS: itches, emotional distress over skin changes
18
![Page 19: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/19.jpg)
Case Two: Exam
VS: T 98.6, HR 105, BP 110/60, RR 14, O2 sat 100%
Skin: large erythematous plaques with overlying scale and crust
19
![Page 20: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/20.jpg)
Case Two, Question 1
What is the most likely diagnosis? a. Atopic dermatitis b. Cutaneous T-cell lymphoma c. Idiopathic d. Pityriasis rubra pilaris e. Psoriatic erythroderma
20
![Page 21: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/21.jpg)
Case Two, Question 1 Answer: a What is the most likely diagnosis?
a. Atopic dermatitis (History of asthma, hay fever and chronic, dry itchy skin suggestive of atopic dermatitis)
b. Cutaneous T-cell lymphoma (Hard to tell the difference, but CTCL erythroderma may present with symmetric islands of uninvolved skin. Also may spare areas of skin that are frequently folded, such as the abdomen)
c. Idiopathic (Possible, but atopic dermatitis more likely given history of atopic disease)
d. Pityriasis rubra pilaris (Typically presents with a reddish orange, scaling dermatitis with islands of normal skin)
e. Psoriatic erythroderma (No history of psoriasis)
21
![Page 22: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/22.jpg)
Case Two, Question 2
Which of the following treatments should take priority in any patient with erythroderma?
a. Leg elevation b. Oral antibiotics c. Remove any potential offending and
unnecessary medications d. Topical corticosteroids
22
![Page 23: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/23.jpg)
Case Two, Question 2
Answer: c Which of the following treatments should take priority in any patient with erythroderma?
a. Leg elevation b. Oral antibiotics c. Remove any potential offending and
unnecessary medications d. Topical corticosteroids
23
![Page 24: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/24.jpg)
Initial Management of Erythroderma
Regardless of the underlying cause, the initial management of erythroderma remains the same
• Remove any potential offending and unnecessary medications
• Address nutrition, fluid and electrolyte balance • Provide local skin care with soaks or wet
dressings to weeping or crusted sites, bland emollients and mid-potency topical corticosteroids
24
![Page 25: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/25.jpg)
Initial Management Continued Oral antihistamines for relief of pruritus (and
anxiety) Warm, humidified environment to prevent
hypothermia and improve moisturization of the skin
Treat secondary infection with systemic antibiotics
Treat peripheral edema with leg elevation Evaluate for signs and systems of cardiac or
respiratory compromise
25
![Page 26: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/26.jpg)
Erythroderma: Prognosis
Prognosis depends on the underlying cause
Determining the underlying etiology and removing any contributing external factors (especially medications) remain the most important factors in treatment
26
![Page 27: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/27.jpg)
Take Home Points
Erythroderma is a clinical manifestation of a variety of underlying diseases
Defined as generalized redness or scaling of the skin, affecting a significant amount of the BSA
Potential risk for morbidity and mortality and hospitalization is often required
Initial management of erythroderma includes removing any potential offending and unnecessary medications
27
![Page 28: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/28.jpg)
Acknowledgements This module was developed by the American
Academy of Dermatology Medical Student Core Curriculum Workgroup from 2008-2012.
Primary authors: Sarah D. Cipriano, MD, MPH; Eric Meinhardt, MD; Timothy G. Berger, MD, FAAD.
Peer reviewers: Peter A. Lio, MD, FAAD; Carlos Garcia, MD.
Revisions: Sarah D. Cipriano, MD, MPH. Last revised August 2011.
28
![Page 29: Erythroderma dermatology 2017](https://reader031.fdocuments.net/reader031/viewer/2022022415/5a6485887f8b9a2c568b5337/html5/thumbnails/29.jpg)
End of the Module Berger T, Hong J, Saeed S, Colaco S, Tsang M, Kasper R. The Web-Based
Illustrated Clinical Dermatology Glossary. MedEdPORTAL; 2007. Available from: www.mededportal.org/publication/462.
Bruno TF, Grewal P. Erythroderma: a dermatologic emergency. CJEM. 2009;11:244-6.
Grant-Kels Jane M, Bernstein Megan L, Rothe Marti J, "Chapter 23. Exfoliative Dermatitis" (Chapter). Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ: Fitzpatrick's Dermatology in General Medicine, 7e.
Rothe MJ, Bernstein ML, Grant-Kels JM. Life-threatening erythroderma: diagnosing and treating the “red man.” Clin Dermatol. 2005;23:206-217.
Rothe MJ, Bialy TL, Grant-Kels JM. Erythroderma. Dermatol Clin. 2000;18:405-15.
Wolff K, Johnson RA, "Section 8. Severe and Life-Threatening Skin Eruptions in the Acutely Ill Patient" (Chapter). Wolff K, Johnson RA: Fitzpatrick's Color Atlas & Synopsis of Clinical Dermatology, 6e: http://www.accessmedicine.com/content.aspx?aID=5201734.
29